SCHEMBL31683835

SCHEMBL31683835

Clc1ncnc2c1sc1nc3ccccc3cc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 1/20 0.57
▸ FLT1 P17948 1/20 0.57
▸ LIMK1 P53667 2/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ PDE4B Q07343 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ CLK1 P49759 8/20 0.39
▸ CDC7 O00311 2/20 0.39
▸ DBF4 Q9UBU7 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ HPGD P15428 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ KMT2A Q03164 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ OPRK1 P41145 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23327861 1.00 CHEK2 (0.57) CHEK2FLT1LIMK1PDE4APDE4B
SCHEMBL12822381 0.83 LIMK1 (0.59) CHEK2FLT1LIMK1CLK1CDC7
SCHEMBL23353119 0.79 PDE4A (0.41) CHEK2FLT1LIMK1PDE4APDE4B
SCHEMBL23353057 0.75 CHEK2 (0.49) CHEK2FLT1LIMK1CLK1CDC7
SCHEMBL23352803 0.75 CHEK2 (0.49) CHEK2FLT1LIMK1CLK1CDC7
SCHEMBL23353114 0.75 CHEK2 (0.49) CHEK2FLT1LIMK1CLK1CDC7
SCHEMBL23352787 0.75 CHEK2 (0.49) CHEK2FLT1LIMK1CLK1CDC7
SCHEMBL19805136 0.74 LIMK1 (0.71) LIMK1CLK1CDC7DBF4ALDH1A1
SCHEMBL23458905 0.73 CHEK2 (1.00) CHEK2FLT1CLK1ALDH1A1MAPT
SCHEMBL31462912 0.73 CHEK2 (1.00) CHEK2FLT1CLK1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 CHEK2 4802/4885FLT1 4013/4885LIMK1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback